Jiaxing Feng

Dr. Jiaxing Feng


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JFJiaxing Feng
Jiaxing Feng
JWJing Wang
Jing Wang
YZYue-Hui Zhang
Yue-Hui Zhang
YZYizhuo Zhang
Yizhuo Zhang
LJLiyan Jia
Liyan Jia
SLShoujuan Luo
Shoujuan Luo
Female infertility is a state of fertility disorder caused by multiple reasons. The incidence of infertility for females has significantly increased due to various factors such as social pressure, late marriage, and late childbirth, and its harm includes heavy economic burden, psychological shadow, and even marriage failure. Conventional solutions, such as hormone therapy, in vitro fertilization (IVF), and embryo transfer, have the limitations of unsatisfied obstetric outcomes and serious adverse events. Currently, complementary and alternative medicine (CAM), as a new treatment for infertility, is gradually challenging the dominant position of traditional therapies in the treatment of infertility. CAM claims that it can adjust and harmonize the state of the female body from a holistic approach to achieve a better therapeutic effect and has been increasingly used by infertile women. Meanwhile, some controversial issues also appeared; that is, some randomized controlled trials (RCTs) confirmed that CAM had no obvious effect on infertility, and the mechanism of its effect could not reach a consensus. To clarify CAM effectiveness, safety, and mechanism, this paper systematically reviewed the literature about its treatment of female infertility collected from PubMed and CNKI databases and mainly introduced acupuncture, moxibustion, and oral Chinese herbal medicine. In addition, we also briefly summarized psychological intervention, biosimilar electrical stimulation, homeopathy, hyperbaric oxygen therapy, etc.

29 April 2025 in Clinical Endocrinology
Verified
Journal Article
Open access
JFJiaxing Feng
Jiaxing Feng
RLRong Luo
Rong Luo
JGJingshu Gao
Jingshu Gao
YWYu Wang
Yu Wang
JCJing Cong
Jing Cong
XWXiao-Ke Wu
Xiao-Ke Wu
Aim: To investigate the associations of triglyceride‐glucose index (TyG) with anthropometric characteristics, metabolic/endocrine profiles, and pregnancy outcomes in Chinese women with polycystic ovary syndrome (PCOS).Methods: This secondary analysis of the Acupuncture and Clomiphene for Chinese Women with Polycystic Ovary Syndrome trial (PCOSAct) included 956 participants with prospectively collected data. TyG was calculated using fasting triglyceride and glucose levels (Ln [TG (mg/dL) × FPG (mg/dL)/2]). Linear regression and trend analyses evaluated relationships between TyG and clinical parameters. Receiver operating characteristic (ROC) curves assessed TyG's predictive capacity for insulin resistance (IR), metabolic syndrome (MS), and nonalcoholic fatty liver disease (NAFLD). Multivariable logistic regression estimated risks for metabolic outcomes and pregnancy outcomes.Results: Linear trends revealed that the TyG was positively associated with age, body mass index (BMI), waist circumference, hip circumference, waist‐to‐hip ratio, systolic blood pressure, diastolic blood pressure, FPG, fasting insulin, the homeostatic model assessment for insulin resistance (HOMA‐IR), total cholesterol, triglycerides, low‐density lipoprotein (LDL), apolipoprotein B, free androgen index, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and the prevalence of IR, MS, and NAFLD across various standards. Conversely, TyG was negatively correlated with the quantitative insulin sensitivity check index (QUICKI), high‐density lipoprotein (HDL), apolipoprotein A1, sex hormone‐binding globulin (SHBG), and the prevalence of ovulation per cycle, conception, pregnancy, and live birth. After adjusting for age and BMI, a significant linear relationship was observed between TyG and components of MS, IR markers, and ALT. The ROC curve analysis indicated that the AUCMS‐IDF was 0.871 (95% CI: 0.846–0.896), with a sensitivity of 81.4% and specificity of 81.2% at a cut‐off value of 8.745, and the AUCIR‐HOMA‐IR was 0.782 (95% CI: 0.753–0.811), with 71.9% sensitivity and 70.3% specificity at a cut‐off of 8.585, and the AUCNAFLD was 0.705 (95% CI: 0.644–0.766), with 76.8% sensitivity and 59.3% specificity at a cut‐off value of 8.665. Logistic regression analysis demonstrated that participants in the highest quartile (Q4) of TyG had significantly higher odds ratios (OR) for MS (OR: 38.36, 95% CI: 20.03–73.46, P‐trend < 0.001) and IR (OR: 12.49, 95% CI: 7.3–21.35, P‐trend < 0.001) compared to those in the lowest quartile (Q1), while NAFLD showed a marginal association (OR: 2.56, 95% CI: 1.00–6.55, P‐trend = 0.069) after adjusting for confounding factors. Conversely, participants in Q1 of TyG had higher OR of conception (OR: 1.56, 95% CI: 1.04–2.35, p < 0.05), pregnancy (OR: 2.35, 95% CI: 1.46–3.79, p < 0.01), and live birth (OR: 2.32, 95% CI: 1.42–3.78, p < 0.01) compared to those in Q4 after adjusting for treatments.Conclusions: Elevated TyG index strongly associates with adverse metabolic trajectories, and adverse pregnancy outcomes in PCOS patients. This biomarker shows particular utility for identifying metabolic dysfunction, suggesting clinical potential for risk stratification in PCOS management.

19 January 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
DWDongmei Wang
Dongmei Wang
YJYue Jiang
Yue Jiang
JFJiaxing Feng
Jiaxing Feng
JGJingshu Gao
Jingshu Gao
JYJinlan Yu
Jinlan Yu
YHYaguang Han
Yaguang Han
Pelvic inflammatory disease (PID), a common infectious disease of the female reproductive tract, is mainly characterized by abdominal/pelvic pain and tenderness of the uterus, cervix, or adnexa on physical exam. In recent years, its incidence has gradually increased yearly due to numerous factors, including sexually transmitted diseases and intrauterine operations. Based on self-report of PID in the National Health and Nutrition Examination Survey (NHANES) 2013–2014 survey, PID impacts approximately 2.5 million women in the US during their reproductive age. Although empiric treatments such as antibiotics or surgery could alleviate the related symptoms of PID, its unsatisfactory obstetric outcome and high relapse bring heavy physical and psychological burden to women. Complementary and alternative medicine (CAM), a complementary therapy other than Western medicine with a complete theoretical and practical system, has been attached to importance in the world due to its remarkable efficacy. More people are accepting and trying to use CAM to treat gynecological diseases, including infertility, polycystic ovary syndrome, and PID, but its efficacy and mechanism are still controversial. This article reviews the previous literature systematically focusing on the effectiveness, safety, and mechanism of CAM in the treatment of PID to provide an evidence-based basis for the clinical application of CAM in patients with PID.

19 August 2025 in Clinical Endocrinology
Verified
Journal Article
Open access
JFJiaxing Feng
Jiaxing Feng
RLRong Luo
Rong Luo
JCJing Cong
Jing Cong
QXQing Xia
Qing Xia
YLYang Liu
Yang Liu
XWXiao-Ke Wu
Xiao-Ke Wu
Aim: To determine whether metabolic syndrome (MS), insulin resistance (IR), myocardial enzymes, and kidney function are related to the normal‐range of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and their ratio in Chinese women with polycystic ovary syndrome (PCOS). Methods: The research, a secondary analysis of the Acupuncture and Clomiphene for Chinese Women with PCOS trial (PCOSAct), enrolled 922 participants with less than 40 U/L of AST and ALT. Linear regression and trend analyses were used to analyze the relationship between AST, ALT, AST/ALT ratio and anthropometric and metabolic characteristics. The association between AST, ALT, AST/ALT ratio and the prevalence of MS, IR was estimated by logistic regression. The diagnostic performance of AST, ALT, and AST/ALT ratio for MS and IR was determined by the receiver operating characteristics (ROC) curve. Results: The results showed that AST was positively associated with body mass index (BMI), waist circumference (WC), systolic/diastole blood pressure (SBP/DBP), triacylglycerol (TG), creatine kinase (CK), lactate dehydrogenase (LDH), creatinine (Cr), urea, cystatin‐C (Cys‐C), and prevalence of MS; negatively correlated with HDL and fasting plasma glucose (FPG). ALT was positively associated with BMI, WC, SBP, DBP, total cholesterol (TC), TG, low‐density lipoprotein (LDL), fasting insulin (FINS), homeostatic model assessment values for insulin resistance (HOMA‐IR), CK, LDH, urea, Cys‐C and prevalence of MS, IR; negatively correlated with HDL and quantitative insulin sensitivity check index (QUICKI). AST/ALT ratio was positively associated with HDL, QUICKI, Cr, Cys‐C; negatively correlated with age, BMI, WC, DBP, TC, TG, LDL, FPG, FINS, HOMA‐IR, LDH and prevalence of MS and IR. Linear regression analysis showed that after adjusting for confounding factors, a positive association between AST and WC, SBP, TG, CK, LDH, Cr, urea and Cys‐C; ALT and WC, TG, FINS, HOMA‐IR, CK, LDH, urea, Cys‐C; AST/ALT ratio and HDL, QUICKI, CK, Cr and Cys‐C; a negative association between AST and HDL, FPG; ALT and HDL, QUICKI; AST/ALT ratio and TG, TC, LDL, FINS, LDH. Univariate logistic regression showed that after adjusted for confounding factors, AST (OR: 1.04; 95% CI: 1.01–1.08, p = 0.022), ALT (OR: 1.04; 95% CI: 1.01–1.07, p = 0.008), and AST/ALT ratio are related to MS (OR: 0.80; 95% CI: 0.64–0.99, p = 0.044), and AST/ALT ratio is related to IR (OR: 0.79; 95% CI: 0.67–0.93, p = 0.005). ROC curve revealed that ALT demonstrated the highest diagnostic performance for MS (AUC = 0.655, 95% CI: 0.61–0.7, cut‐off value = 7.5, Sensitive = 0.60, and Specificity = 0.63), whereas AST/ALT ratio was more strongly associated with IR (AUC = 0.619, 95% CI: 0.58–0.66, cut‐off value = 1.52, sensitive = 0.64, and specificity = 0.56). Conclusions: In Chinese PCOS patients, normal‐range elevations in ALT and AST along with a lower AST/ALT ratio were associated with more severe manifestations of MS components, and ALT was more specific in predicting MS. Moreover, patients with higher ALT and lower AST/ALT ratios tend to exhibit more severe IR, and their ratio is superior to predict IR. The increased ALT and AST were associated with elevated myocardial enzymes, and ALT is the most sensitive indicator of renal impairment. It reinforces the need for PCOS‐specific enzyme reference ranges.

21 December 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
MHMin Hu
Min Hu
YZYue-Hui Zhang
Yue-Hui Zhang
JFJiaxing Feng
Jiaxing Feng
XXXue Xu
Xue Xu
JZJiao Zhang
Jiao Zhang
HBHåkan Billig
Håkan Billig
Impaired progesterone (P4) signaling is linked to endometrial dysfunction and infertility in women with polycystic ovary syndrome (PCOS). Here we report for the first time that elevated expression of progesterone receptor (PGR) isoforms A and B parallels increased estrogen receptor (ER) expression in PCOS-like rat uteri. The aberrant PGR-targeted gene expression in PCOS-like rats before and after implantation overlaps with dysregulated expression of Fkbp52 and Ncoa2 , two genes that contribute to the development of uterine P4 resistance. In vivo and in vitro studies of the effects of metformin on the regulation of the uterine P4 signaling pathway under PCOS conditions showed that metformin directly inhibits the expression of PGR and ER along with the regulation of several genes that are targeted dependently or independently of PGR-mediated uterine implantation. Functionally, metformin treatment corrected the abnormal expression of cell-specific PGR and ER and some PGR-target genes in PCOS-like rats with implantation. Additionally, we documented how metformin contributes to the regulation of the PGR-associated MAPK/ERK/p38 signaling pathway in the PCOS-like rat uterus. Our data provide novel insights into how metformin therapy regulates uterine P4 signaling molecules under PCOS conditions.